Skip to main content

Clinical Trials in the Time of COVID-19


Date: April 21, 2020

Time: 1:00PM - 2:00PM (EST)

Location: View the Webinar Recording

Join Mintz for the next installment in our COVID-19 webinar series for life sciences companies. This session will explore the widespread disruptions the crisis is posing to clinical trials for life sciences companies and to research study sites. We will also discuss recent guidance from regulatory authorities and practical steps for both sponsors and researchers to address emerging issues. 

The program will cover the following topics:
•    Regulatory authority accommodations for ongoing clinical trials that may be affected by COVID-19 and  regional restrictions
•    Overview of the current clinical trials landscape during the COVID-19 pandemic
•    Key considerations for sponsors and study sites regarding ongoing and planned clinical trials
•    Considerations for companies interested in commencing a clinical trial for a COVID-19 product candidate


Dianne J. Bourque advises health care clients on licensure, regulatory, contractual, risk management, and patient care matters for Mintz. Dianne counsels researchers and research sponsors on FDA and OHRP regulations. She also counsels clients on data privacy issues, including HIPAA standards.
Benjamin M. Zegarelli is a Mintz Associate who counsels clients on compliance and regulatory issues, with a focus on FDA regulations. Benjamin advises clients in the pharmaceutical, medical device, and biotech industries. He provides counsel on research approval, sales, and contract negotiations.

More Events


FDA in the Time of COVID-19

View the Webinar Recording